Combined Anabolic Therapy

NCT06558188 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis, Postmenopausal
Osteoporosis

Interventions

DRUG: Romosozumab
DRUG: Teriparatide

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]